- Home
- UWMC vs LENZ Comparison
UWMC vs LENZ Comparison
Compare UWMC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UWMC
- LENZ
- Stock Information
- Founded
- UWMC 1986
- LENZ 2019
- Country
- UWMC United States
- LENZ United States
- Employees
- UWMC N/A
- LENZ N/A
- Industry
- UWMC Finance: Consumer Services
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- UWMC Finance
- LENZ Health Care
- Exchange
- UWMC Nasdaq
- LENZ Nasdaq
- Market Cap
- UWMC 1.4B
- LENZ 1.1B
- IPO Year
- UWMC N/A
- LENZ 2021
- Fundamental
- Price
- UWMC $6.55
- LENZ $41.76
- Analyst Decision
- UWMC Hold
- LENZ Strong Buy
- Analyst Count
- UWMC 7
- LENZ 4
- Target Price
- UWMC $5.54
- LENZ $49.75
- AVG Volume (30 Days)
- UWMC 8.2M
- LENZ 411.0K
- Earning Date
- UWMC 11-06-2025
- LENZ 11-05-2025
- Dividend Yield
- UWMC 5.97%
- LENZ N/A
- EPS Growth
- UWMC 112.84
- LENZ N/A
- EPS
- UWMC 0.07
- LENZ N/A
- Revenue
- UWMC $2,622,828,000.00
- LENZ $5,000,000.00
- Revenue This Year
- UWMC $25.96
- LENZ N/A
- Revenue Next Year
- UWMC N/A
- LENZ $258.37
- P/E Ratio
- UWMC $101.16
- LENZ N/A
- Revenue Growth
- UWMC 13.45
- LENZ N/A
- 52 Week Low
- UWMC $3.80
- LENZ $16.54
- 52 Week High
- UWMC $9.17
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- UWMC 65.10
- LENZ 60.46
- Support Level
- UWMC $5.50
- LENZ $39.62
- Resistance Level
- UWMC $7.09
- LENZ $41.80
- Average True Range (ATR)
- UWMC 0.24
- LENZ 2.01
- MACD
- UWMC -0.00
- LENZ -0.03
- Stochastic Oscillator
- UWMC 64.94
- LENZ 70.27
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.